November 20, 2019

Astellas and Welldoc Enter into Strategic Alliance for Digital Therapeutics

TOKYO and COLUMBIA, Md., Nov. 20, 2019 /PRNewswire/ — Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D., “Astellas” ) and Welldoc, Inc. (President, CEO: Kevin McRaith, “Welldoc”) today announced that the companies have entered … Continued